Acro Biomedical (ACBM) Accounts Payables (2015 - 2025)
Acro Biomedical's quarterly Accounts Payables came in at $55550.0 in Q4 2025, down 64.04% year-on-year from $154460.0 in Q4 2024, and down 52.35% quarter-over-quarter from $116582.0 in Q3 2025.
Acro Biomedical has reported Accounts Payables for 11 years, with the latest figure at $55550.0 in Q4 2025.
- For the quarter ending Q4 2025, Accounts Payables fell 64.04% year-over-year to $55550.0; the trailing twelve-month figure through Dec 2025 stood at $55550.0 (down 64.04% YoY), and the FY2025 full-year result was $55550.0, down 64.04% from the prior year.
- Accounts Payables for Q4 2025 stood at $55550.0, down from $116582.0 in the prior quarter.
- The five-year high for Accounts Payables was $155507.0 in Q3 2024, with the low at $12072.0 in Q2 2021.
- Average Accounts Payables over 5 years is $91025.6, with a median of $95493.0 recorded in 2025.
- Year-over-year, Accounts Payables surged 1026.12% in 2021 and tumbled 64.04% in 2025.
- Tracing ACBM's Accounts Payables over 5 years: stood at $26197.0 in 2021, then surged by 192.29% to $76571.0 in 2022, then surged by 101.7% to $154444.0 in 2023, then grew by 0.01% to $154460.0 in 2024, then plunged by 64.04% to $55550.0 in 2025.
- The last three Accounts Payables figures came in at $55550.0 (Q4 2025), $116582.0 (Q3 2025), and $95493.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | 167,813.00 |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | 144,789.00 |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | 56,828.00 |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | 39,602.00 |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | 66,145.00 |
| 10 | Acro Biomedical | - | - | - | 55,550.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55,550.00 |
| Sep 30, 2025 | 116,582.00 |
| Jun 30, 2025 | 95,493.00 |
| Mar 31, 2025 | 143,178.00 |
| Dec 31, 2024 | 154,460.00 |
| Sep 30, 2024 | 155,507.00 |
| Jun 30, 2024 | 152,736.00 |
| Mar 31, 2024 | 152,294.00 |
| Dec 31, 2023 | 154,444.00 |
| Sep 30, 2023 | 153,036.00 |
| Jun 30, 2023 | 87,536.00 |
| Mar 31, 2023 | 127,786.00 |
| Dec 31, 2022 | 76,571.00 |
| Sep 30, 2022 | 20,900.00 |
| Jun 30, 2022 | 15,000.00 |
| Dec 31, 2021 | 26,197.00 |
| Sep 30, 2021 | 16,072.00 |
| Jun 30, 2021 | 12,072.00 |
| Mar 31, 2021 | 14,072.00 |
| Dec 30, 2020 | 24,734.00 |
| Sep 30, 2020 | 5,072.00 |
| Jun 30, 2020 | 1,072.00 |
| Mar 31, 2020 | 15,072.00 |
| Dec 31, 2019 | 23,834.00 |
| Sep 30, 2019 | 18,024.00 |
| Jun 30, 2019 | 9,690.00 |
| Mar 31, 2019 | 10,618.00 |
| Dec 31, 2018 | 7,582.00 |
| Sep 30, 2018 | 7,312.00 |
| Jun 30, 2018 | 3,876.00 |
| Mar 31, 2018 | 18,242.00 |
| Dec 31, 2017 | 66,624.00 |
| Sep 30, 2017 | 600.00 |
| Jun 30, 2017 | 4,400.00 |
| Mar 31, 2017 | 9,567.00 |
| Dec 31, 2016 | 14,597.00 |
| Sep 30, 2016 | 7,326.00 |
| Jun 30, 2016 | 11,007.00 |
| Mar 31, 2016 | 3,283.00 |
| Sep 30, 2015 | 825.00 |